The Fraser Eye Care Center Doctors have either authored or reviewed and approved this content.
Menu
Fraser Eye Center is committed to improving eyesight for residents of Detroit and all of Michigan with a variety of vision correction procedures. Our experienced ophthalmologists offer the implantable contact lens procedure with EVO ICL, an innovative procedure that can significantly improve vision for patients who may not be candidates for LASIK because of thin corneas1. EVO ICL is also an ideal and highly effective vision correction solution where the eye is not permanently altered.
EVO ICL is an Implantable Collamer Lens. This is a micro-thin lens implant made of a soft, 100% biocompatible material that also provides UV protection. The EVO ICL can be implanted in the eye during a brief procedure to correct myopia (nearsightedness) or astigmatism. This can be a permanent solution to a patient’s vision needs, but it can also be reversed or upgraded if necessary.
To date, more than 1 million EVO ICL lenses have been implanted across the world. This remarkable lens allows us to provide our patients with vision so clear and sharp that many are able to get rid of their eyeglasses and contact lenses entirely.2
There are several factors that differentiate EVO ICL from LASIK. Unlike LASIK, the EVO ICL procedure does not use lasers and it does not alter the shape of the cornea. The results of EVO ICL are immediate, and, unlike LASIK, the procedure can be reversed if the patient wishes to have the implantable contact lens removed.
– Comedian, Jimmy O. Yang
There are so many reasons our patients love the EVO ICL:
The eye surgeon will begin the EVO ICL process by placing numbing drops on the eyes and offering you a mild sedative to ensure your comfort during the procedure. The surgeon will make a very small incision and place the lens in the eye. Results are immediate and unlike a regular contact lens, you will not be able to feel the EVO ICL and other people will not be able to see it.
Patients typically require very little downtime after the EVO ICL procedure and may return to work as soon as two days after surgery. Visual improvement is experienced the same day and studies show a very high satisfaction rate with the results of Implantable Contact Lens (ICL) procedures.7
$1,882/eye
$1,882/eye
$1,882/eye
Varies, depending on lens implant
Quick (24-48 hrs)
2-4 Weeks
1-2 weeks
1-2 weeks
10 Minutes
10 Minutes
20-30 Minutes
15-20 Minutes
Yes, up to -12D
Yes, up to -12D
Yes, up to -20D
Yes, up to -26D
Yes, up to +5D
Yes, up to +5D
Yes, up to +10D
Yes, with Monovision
Yes, with Monovision
Yes, with multifocal IOLs
Yes, during recovery
A little, during recovery
If you would like more information about the Implantable Collamer Lens (ICL) procedure with EVO ICL, we would be happy to help you in your pursuit of clear vision. Contact us with any questions or to schedule a consultation at one of our convenient Michigan locations.
Who is a candidate for EVO ICL?
Will I be able to feel or see the implanted lens in my eye?
Can I afford EVO ICL?
1Parkhurst GD, Psolka M, Kezirian GM. Phakic intraocular lens implantation in United States military warfighters: a retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011 Jul;27(7):473-81. doi: 10.3928/1081597X-20110106-03. Epub 2011 Jan 17. PMID: 21243974. Available: https://pubmed.ncbi.nlm.nih.gov/21243974/. Accessed November 11, 2021.
2Sanders D, Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for low myopia. Cornea. 2006 Dec;25(10):1139-46. doi: 10.1097/ICO.0b013e31802cbf3c. PMID: 17172886. Available: https://pubmed.ncbi.nlm.nih.gov/17172886/. Accessed November 11, 2021.
3Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Ophthalmol. 2009 Jul;148(1):164-70.e1. doi: 10.1016/j.ajo.2009.02.001. Epub 2009 Apr 17. PMID: 19375059. Available: https://pubmed.ncbi.nlm.nih.gov/19375059/. Accessed November 11, 2021.
4Gimbel HV, Ziémba SL. Management of myopic astigmatism with phakic intraocular lens implantation. J Cataract Refract Surg. 2002 May;28(5):883-6. doi: 10.1016/s0886-3350(01)01098-7. PMID: 11978472. Available: https://pubmed.ncbi.nlm.nih.gov/11978472/. Accessed November 11, 2021.
5Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263. doi: 10.2147/OPTH.S127101. PMID: 28740361; PMCID: PMC5505606. Available: https://pubmed.ncbi.nlm.nih.gov/28740361/. Accessed November 11, 2021
6Martínez-Plaza E, López-Miguel A, López-de la Rosa A, McAlinden C, Fernández I, Maldonado MJ. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021 Jun;226:117-125. doi: 10.1016/j.ajo.2021.02.005. Epub 2021 Feb 9. PMID: 33577790. Available: https://pubmed.ncbi.nlm.nih.gov/33577790/. Accessed November 11 2021.
7Bamashmus MA, Al-Arabi AH, Alawad MA. Visual outcomes and patient satisfaction after implantable collamer lens and Toric implantable collamer lens correction for moderate to high myopia and myopic astigmatism. Saudi Med J. 2013 Sep;34(9):913-9. PMID: 24043002. Available: https://pubmed.ncbi.nlm.nih.gov/24043002/. Accessed November 11, 2021.
The Fraser Eye Care Center Doctors have either authored or reviewed and approved this content.
